ArticleCureus2024
Characteristics of Nodular Goitre and Its Correlation With Papillary Thyroid Carcinoma: A Cross-Sectional Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective To investigate the clinical characteristics of nodular goitre (NG) and the relationship between NG and papillary thyroid carcinoma (PTC). Methods A total of 282 consecutive patients suspicious for thyroid cancer were enrolled. All the patients underwent surgical resection of the thyroid. Laboratory tests, ultrasonography, and pathology data were compared between patients with and without NG. Results Of the 282 patients who underwent surgery, 124 were diagnosed with PTC by pathology. NG accounted for 48.9% (138/282) of all patients, with a male-to-female ratio of 1:3. The rates of PTC and haemorrhage in patients with NG were 23.2% (31/138) and 29.0% (40/138), respectively, both of which were greater than those in patients without NG (p < 0.001). The levels of thyroid-stimulating hormone (TSH) and carcinoembryonic antigen (CEA) in patients with PTC were 2.2 µIU/mL (min, 0.4; max, 109.8) (p = 0.04) and 1.16 ng/mL (0, 2.17, p25, p75) (p < 0.001), respectively, both of which were greater than those in patients with NG. However, the levels of thyroglobulin, thyroglobulin antibodies, and thyroid peroxidase antibodies were not significantly different. Conclusions The proportion of NG in thyroid surgery is very high, and NG carries a high risk of PTC, suggesting that elevated TSH and CEA are closely related to PTC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.